119 related articles for article (PubMed ID: 6454333)
1. Normal and malignant T cells in the regulation of inflammation and immunity.
Broder S
Agents Actions Suppl; 1980; 7():134-42. PubMed ID: 6454333
[TBL] [Abstract][Full Text] [Related]
2. Neoplasms of immunoregulatory cells.
Broder S; Uchiyama T; Waldmann TA
Am J Clin Pathol; 1979 Oct; 72(4 Suppl):724-31. PubMed ID: 158979
[TBL] [Abstract][Full Text] [Related]
3. Neoplasms of immunoregulatory T cells in clinical investigation.
Broder S; Muul L; Marshall S; Waldmann TA
J Invest Dermatol; 1980 May; 74(5):267-71. PubMed ID: 6967093
[TBL] [Abstract][Full Text] [Related]
4. Current concepts in immunoregulatory T-cell neoplasms.
Broder S; Uchiyama T; Waldmann TA
Cancer Treat Rep; 1979 Apr; 63(4):607-12. PubMed ID: 312696
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the humoral immune response: from immunoglobulin genes to regulatory T cell networks.
Waldmann TA; Korsmeyer SJ; Hieter PA; Ravetch JV; Broder S; Leder P
Fed Proc; 1983 May; 42(8):2498-503. PubMed ID: 6404657
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of immunoregulatory cells in immunodeficiency disease and cancer.
Broder S; Muul L; Megson M; Waldmann TA
Prog Clin Biol Res; 1981; 58():93-120. PubMed ID: 6455670
[No Abstract] [Full Text] [Related]
7. [T-cell neoplasms with helper or suppressor activity].
Rupniewska ZM
Acta Haematol Pol; 1981; 12(1):53-61. PubMed ID: 6458988
[No Abstract] [Full Text] [Related]
8. T cells in cutaneous lesions of Sézary syndrome and T-cell leukemia. Characterization by monoclonal antibodies.
Buechner SA; Winkelmann RK; Banks PM
Arch Dermatol; 1983 Nov; 119(11):895-900. PubMed ID: 6227293
[TBL] [Abstract][Full Text] [Related]
9. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas.
Kamoun M; Kadin ME; Martin PJ; Nettleton J; Hansen JA
J Immunol; 1981 Sep; 127(3):987-91. PubMed ID: 6790625
[TBL] [Abstract][Full Text] [Related]
10. Activation of leukemic pro-suppressor cells to become suppressor-effector cells. Influence of cooperating normal T cells.
Broder S; Uchiyama T; Muul LM; Goldman C; Sharrow S; Poplack DG; Waldmann TA
N Engl J Med; 1981 Jun; 304(23):1382-7. PubMed ID: 6453293
[TBL] [Abstract][Full Text] [Related]
11. [Immunologic phenotyping of cutaneous lymphomas].
Kaudewitz P; Burg G; Smolle J; Braun-Falco O
Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
[TBL] [Abstract][Full Text] [Related]
12. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the cutaneous T cell lymphomas.
Edelson RL
Bull Cancer; 1977; 64(2):209-24. PubMed ID: 303131
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome.
Leung DY; Chu ET; Wood N; Grady S; Meade R; Geha RS
J Immunol; 1983 May; 130(5):2002-4. PubMed ID: 6220072
[TBL] [Abstract][Full Text] [Related]
15. Results of multiparameter studies of T-cell lymphoid neoplasms.
Collins RD; Waldron JA; Glick AD
Am J Clin Pathol; 1979 Oct; 72(4 Suppl):699-707. PubMed ID: 386780
[TBL] [Abstract][Full Text] [Related]
16. [Membrane markers of lymphoid cells in immunoproliferative diseases of man].
Seligmann M; Brouet JC; Preud'homme JL
Z Gesamte Inn Med; 1980 Jan; 35(2):66-9. PubMed ID: 6996351
[TBL] [Abstract][Full Text] [Related]
17. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
[TBL] [Abstract][Full Text] [Related]
18. Anti-ATLA (antibody to adult T-cell leukemia virus-associated antigen), highly positive in OKT4-positive mature T-cell malignancies.
Tobinai K; Nagai M; Setoya T; Shibata T; Minato K; Shimoyama M
Jpn J Clin Oncol; 1983; 13 Suppl 2():237-44. PubMed ID: 6603532
[TBL] [Abstract][Full Text] [Related]
19. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
Schmitt D; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
[TBL] [Abstract][Full Text] [Related]
20. [Chronic lymphocytic leukemia of T-cells with a suppressor phenotype (T3+, T4-, T8+). Report of 2 cases].
Calabuig MT; Outeiriño J; Escudero A; Prieto ME; Pérez-Rus MG; Pérez Sánchez MI; Méndez MM; Sánchez-Fayos J
Sangre (Barc); 1984; 29(4-A):449-56. PubMed ID: 6239401
[No Abstract] [Full Text] [Related]
[Next] [New Search]
